{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:22:18Z","timestamp":1794018138984,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017618","name":"National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.metabol.2026.156571","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:41:11Z","timestamp":1772005271000},"page":"156571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Hyperinsulinemia drives glomerular podocyte injury and albuminuria via a self-perpetuating GSK3\u03b2\u2013IRS1 insulin desensitization circuit"],"prefix":"10.1016","volume":"179","author":[{"given":"Mengxuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Junejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.metabol.2026.156571_bb0005","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156571_bb0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.metabol.2026.156571_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI5001","article-title":"Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity","volume":"103","author":"Dresner","year":"1999","journal-title":"J Clin Invest"},{"issue":"6801","key":"10.1016\/j.metabol.2026.156571_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35025089","article-title":"CAP defines a second signalling pathway required for insulin-stimulated glucose transport","volume":"407","author":"Baumann","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2007.04.002","article-title":"Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences","volume":"47","author":"Leclercq","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2026.156571_bb0035","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1038\/ncomms8906","article-title":"Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements","volume":"6","author":"Morley","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.metabol.2026.156571_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM198908103210601","article-title":"Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus","volume":"321","author":"Eriksson","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2026.156571_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154737","article-title":"Diabetes mellitus: 100\u00a0years since the discovery of insulin","volume":"118","author":"Polyzos","year":"2021","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2026.156571_bb0050","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2337\/dc09-0153","article-title":"Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report","volume":"32","author":"Dankner","year":"2009","journal-title":"Diabetes Care"},{"issue":"1a","key":"10.1016\/j.metabol.2026.156571_bb0055","doi-asserted-by":"crossref","first-page":"11s","DOI":"10.1016\/0002-9343(91)90058-6","article-title":"Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia","volume":"91","author":"Flack","year":"1991","journal-title":"Am J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2026.156571_bb0060","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.metabol.2026.156571_bb0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM199907223410406","article-title":"Glucose transporters and insulin action\u2014implications for insulin resistance and diabetes mellitus","volume":"341","author":"Shepherd","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.metabol.2026.156571_bb0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI10842","article-title":"Obesity and insulin resistance","volume":"106","author":"Kahn","year":"2000","journal-title":"J Clin Invest"},{"issue":"16","key":"10.1016\/j.metabol.2026.156571_bb0075","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1042\/CS20200022","article-title":"Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments","volume":"134","author":"Clarembeau","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00004872-199715010-00008","article-title":"Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension","volume":"15","author":"Redon","year":"1997","journal-title":"J Hypertens"},{"issue":"11","key":"10.1016\/j.metabol.2026.156571_bb0085","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.2337\/diabetes.54.11.3095","article-title":"The human glomerular podocyte is a novel target for insulin action","volume":"54","author":"Coward","year":"2005","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.metabol.2026.156571_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","article-title":"Insulin signaling to the glomerular podocyte is critical for normal kidney function","volume":"12","author":"Welsh","year":"2010","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-021-01936-3","article-title":"Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study","volume":"19","author":"Penno","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.metabol.2026.156571_bb0100","doi-asserted-by":"crossref","first-page":"4709715","DOI":"10.1155\/2019\/4709715","article-title":"Hyperinsulinemia can cause kidney disease in the IGT stage of OLETF rats via the INS\/IRS-1\/PI3-K\/Akt signaling pathway","volume":"2019","author":"Zhang","year":"2019","journal-title":"J Diabetes Res"},{"issue":"2","key":"10.1016\/j.metabol.2026.156571_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ki.2009.137","article-title":"The link between obesity and albuminuria: adiponectin and podocyte dysfunction","volume":"76","author":"Sharma","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.metabol.2026.156571_bb0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.14740\/jem666","article-title":"Difficulties in correction of recurrent hypoglycemia in a patient with a progressive course of malignant metastatic insulinoma","volume":"10","author":"Tsygankova","year":"2020","journal-title":"J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(95)05631-9","article-title":"Insulin sensitivity in clinically healthy individuals with microalbuminuria","volume":"119","author":"Jensen","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2026.156571_bb0120","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1111\/j.1523-1755.2004.09216.x","article-title":"Glomerular filtration of albumin: how small is the sieving coefficient?","volume":"92","author":"Deen","year":"2004","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.metabol.2026.156571_bb0125","doi-asserted-by":"crossref","first-page":"F173","DOI":"10.1152\/ajprenal.2000.278.2.F173","article-title":"Roles of the podocyte in glomerular function","volume":"278","author":"Pavenst\u00e4dt","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156571_bb0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.kint.2025.01.009","article-title":"Melanocortin 5 receptor signaling protects against podocyte injury in proteinuric glomerulopathies","volume":"107","author":"Chen","year":"2025","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.metabol.2026.156571_bb0135","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.2337\/db16-1213","article-title":"Pair feeding, but not insulin, phloridzin, or rosiglitazone treatment, curtails markers of \u03b2-cell dedifferentiation in db\/db mice","volume":"66","author":"Ishida","year":"2017","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.metabol.2026.156571_bb0140","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s10495-014-1037-5","article-title":"Enhanced glycogen synthase kinase-3\u03b2 activity mediates podocyte apoptosis under diabetic conditions","volume":"19","author":"Paeng","year":"2014","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.metabol.2026.156571_bb0145","doi-asserted-by":"crossref","first-page":"F515","DOI":"10.1152\/ajprenal.00080.2022","article-title":"Podocytes are lost from glomeruli before completing apoptosis","volume":"323","author":"Yamamoto","year":"2022","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10.1016\/j.metabol.2026.156571_bb0150","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00125-017-4394-0","article-title":"Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor","volume":"60","author":"Lay","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.metabol.2026.156571_bb0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrendo.2017.161","article-title":"Animal models of obesity and diabetes mellitus","volume":"14","author":"Kleinert","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.metabol.2026.156571_bb0160","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00125-016-3942-3","article-title":"Changes in beta cell function occur in prediabetes and early disease in the Lepr (db) mouse model of diabetes","volume":"59","author":"Do","year":"2016","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.metabol.2026.156571_bb0165","doi-asserted-by":"crossref","first-page":"R1846","DOI":"10.1152\/ajpregu.00461.2007","article-title":"Obese OLETF rats exhibit increased operant performance for palatable sucrose solutions and differential sensitivity to D2 receptor antagonism","volume":"293","author":"Hajnal","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2026.156571_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103127","article-title":"The redox-sensitive GSK3\u03b2 is a key regulator of glomerular podocyte injury in type 2 diabetic kidney disease","volume":"72","author":"Chen","year":"2024","journal-title":"Redox Biol"},{"issue":"10","key":"10.1016\/j.metabol.2026.156571_bb0175","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1681\/ASN.2020020220","article-title":"Single-cell transcriptome profiling of the kidney glomerulus identifies key cell types and reactions to injury","volume":"31","author":"Chung","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"39","key":"10.1016\/j.metabol.2026.156571_bb0180","doi-asserted-by":"crossref","first-page":"19619","DOI":"10.1073\/pnas.1908706116","article-title":"The single-cell transcriptomic landscape of early human diabetic nephropathy","volume":"116","author":"Wilson","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.metabol.2026.156571_bb0185","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1074\/jbc.M410610200","article-title":"Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling","volume":"280","author":"Liberman","year":"2005","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.metabol.2026.156571_bb0190","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141279","article-title":"DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity","volume":"131","author":"Cao","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.metabol.2026.156571_bb0200","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","article-title":"A phase 2 study of AMO-02 (Tideglusib) in congenital and childhood-onset myotonic dystrophy type 1 (DM1)","volume":"112","author":"Horrigan","year":"2020","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.metabol.2026.156571_bb0205","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.metabol.2026.156571_bb0210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13679-017-0261-z","article-title":"Hyperinsulinemia: a cause of obesity?","volume":"6","author":"Erion","year":"2017","journal-title":"Curr Obes Rep"},{"issue":"12","key":"10.1016\/j.metabol.2026.156571_bb0215","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2337\/dc12-0684","article-title":"Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence","volume":"35","author":"Pories","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156571_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gfs290","article-title":"Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence","volume":"28","author":"De Cosmo","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.metabol.2026.156571_bb0230","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2337\/dc10-1718","article-title":"Association between insulin resistance and development of microalbuminuria in type 2 diabetes: a prospective cohort study","volume":"34","author":"Hsu","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.metabol.2026.156571_bb0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-8227(01)00241-8","article-title":"Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 years follow up study","volume":"53","author":"Fujikawa","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.metabol.2026.156571_bb0240","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","article-title":"Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease","volume":"53","author":"Fliser","year":"1998","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.metabol.2026.156571_bb0245","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2362.2000.00749.x","article-title":"Insulin-mediated increases in renal plasma flow are impaired in insulin-resistant normal subjects","volume":"30","author":"Ter Maaten","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.metabol.2026.156571_bb0250","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/dc13-2573","article-title":"Insulin sensitivity and albuminuria: the RISC study","volume":"37","author":"Pilz","year":"2014","journal-title":"Diabetes Care"},{"issue":"S1","key":"10.1016\/j.metabol.2026.156571_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.02118","article-title":"Renal hyperinsulinemia causes thickening of glomerular basement membrane independent of hypertension and hyperglycemia","volume":"34","author":"Monu","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2026.156571_bb0260","article-title":"What Are the bona fide GSK3 substrates?","volume":"2011","author":"Sutherland","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2026.156571_bb0265","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2016.02.002","article-title":"Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy","volume":"93","author":"Cheng","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"10.1016\/j.metabol.2026.156571_bb0270","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1681\/ASN.2015050565","article-title":"Genetic and pharmacologic targeting of glycogen synthase kinase 3\u03b2 reinforces the Nrf2 antioxidant defense against podocytopathy","volume":"27","author":"Zhou","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/path.4692","article-title":"The \u03b2 isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy","volume":"239","author":"Li","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.metabol.2026.156571_bb0280","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/749010","article-title":"The glomerular filtration barrier: components and crosstalk","volume":"2012","author":"Menon","year":"2012","journal-title":"Int J Nephrol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156571_bb0285","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s42255-025-01226-9","article-title":"A short-term, high-caloric diet has prolonged effects on brain insulin action in men","volume":"7","author":"Kullmann","year":"2025","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156571_bb0290","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1038\/s41467-024-53886-y","article-title":"GSK3 inhibition improves skeletal muscle function and whole-body metabolism in male mouse models of Duchenne muscular dystrophy","volume":"15","author":"Marcella","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.metabol.2026.156571_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020255","article-title":"Lithium and therapeutic targeting of GSK-3","volume":"10","author":"Snitow","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.metabol.2026.156571_bb0300","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/diab.38.5.648","article-title":"Normalization of insulin sensitivity with lithium in diabetic rats","volume":"38","author":"Rossetti","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156571_bb0305","article-title":"Effects of lithium therapy on blood glucose and insulin levels in individuals with bipolar disorder: a systematic review","volume":"404","author":"Kanter-Eivin","year":"2025","journal-title":"J Affect Disord"},{"issue":"5","key":"10.1016\/j.metabol.2026.156571_bb0310","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/dc06-0291","article-title":"Transient diabetes associated with withdrawal of lithium therapy","volume":"29","author":"Okosieme","year":"2006","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.metabol.2026.156571_bb0315","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1101\/gr.155697.113","article-title":"Defining cell-type specificity at the transcriptional level in human disease","volume":"23","author":"Ju","year":"2013","journal-title":"Genome Res"},{"issue":"8","key":"10.1016\/j.metabol.2026.156571_bb0320","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/jcpe.14180","article-title":"Glomerular haematopoietic prostaglandin D synthase-prostaglandin D2 axis contributes to the periodontitis-related exacerbation of diabetic nephropathy in KK-A(y) mice","volume":"52","author":"Sato","year":"2025","journal-title":"J Clin Periodontol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:10:36Z","timestamp":1779163836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":64,"alternative-id":["S0026049526000818"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156571","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperinsulinemia drives glomerular podocyte injury and albuminuria via a self-perpetuating GSK3\u03b2\u2013IRS1 insulin desensitization circuit","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156571"}}